DNA vaccines for bacterial infections

Immunology and Cell Biology

Volumn 75, Issue 4, 1997, Pages 364-369

  Strugnell, R A ^a   Drew, D ^a   Mercieca, J ^a,b   Dinatale, S ^a   Firez, N ^a   Dunstan, S J ^a   Simmons, C P ^a   Vadolas, J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CSL LIMITED   (Australia)

Author keywords

Bacteria; Chlamydia; DNA vaccines; Mycobacterium

Indexed keywords

BCG VACCINE; DNA VACCINE; SALMONELLOSIS VACCINE; TETANUS TOXOID;

BACTERIAL INFECTION; CHLAMYDIASIS; GRAM NEGATIVE INFECTION; HUMORAL IMMUNITY; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; LYME DISEASE; NONHUMAN; REVIEW; SALMONELLOSIS; TETANUS; TUBERCULOSIS;

BACTERIA (MICROORGANISMS); CHLAMYDIA; EUKARYOTA; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NEGIBACTERIA; PROKARYOTA; RODENTIA;

EID: 0030931163     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1997.57     Document Type: Review

References (24)

1. Ada G. Global aspects of vaccination. Int. Arch. Allergy Immunol. 1995; 108: 304-8.
2. Kaufmann SH. Immunity to intracellular microbial pathogens. Immunol. Today 1995; 16: 338-42.
3. The role of BCG vaccine in the prevention and control of tuberculosis in the United States: A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR Morb. Mortal Wkly Rep. 1996; 45: 1-18.
4. Hone DM, Attridge SR, Forrest B et al. A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans. Infect. Immun. 1988; 56: 1326-33.
5. Tacket CO, Sztein MB, Losonsky GA et al. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect. Immun. 1997; 65: 452-6.
6. Pascual DW, VanCott JL, Hone DM et al. Some attenuated recombinant (r) Salmonella vaccine vectors are lethal in IFN-γ-/- gene-disrupted mice: what constitutes safe attenuation. Clin. Immunol. Immunopathol. 1995; 76 (Suppl. 1): S5.
7. Barry MA, Lai WC, Johnston SA. Protection against mycoplasma infection using expression-library immunization. Nature 1995; 377: 632-5.
8. Moore MW, Carbone FR, Bevan MJ. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988; 54: 777-85.
9. Pamer EG, Harty JT, Bevan MJ. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature 1991; 353: 852-5.
10. Starnbach MN, Bevan MJ, Lampe MF. Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis. J. Immunol. 1994; 153: 5183-9.
11. Turner SJ, Carbone FR, Strugnell RA. Salmonella typhimurium aroA aroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T lymphocytes in mice. Infect. Immun. 1993; 61: 5374-80.
12. + TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location. J. Immunol. 1996; 156: 3321-6.
13. Lowrie DB, Tascon RE, Colston MJ, Silva CL. Towards a DNA vaccine against tuberculosis. Vaccine 94 1994; 12: 1537-40.
14. Tascon RE, Colston MJ, Ragno S, Stavropoulos E, Gregory D, Lowrie DB. Vaccination against tuberculosis by DNA injection. Nat. Med. 1996; 2: 888-92.
15. Huygen K, Content J, Denis O et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 1996; 2: 893-8.
16. Luke CJ, Carner K, Liang X, Barbour AG. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi. J. Infect. Dis. 1997; 175: 91-7.
17. Lopez-Macias C, Lopez-Hernandez MA, Gonzalez CR, Isibasi A, Ortiz-Navarrete V. Induction of antibodies against Salmonella typhi OmpC porin by naked DNA immunization. Ann. NY Acad. Sci. 1995; 772; 285-8.
18. Anderson R, Gao XM, Papakonstantinopoulou A. Roberts M, Dougan G. Immune response in mice following immunization with DNA encoding fragment C of tetanus toxin. Infect. Immun. 1996; 64: 3168-73.
19. Baehr W, Zhang YX, Joseph T et al. Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc. Natl Acad. Sci. USA 1988; 85: 4000-4.
20. Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 1987; 15: 8125-48.
21. Zhang D, Yang X, Berry J, Shen C, McClarty G, Brunham RC. Molecular approaches to the control of infectious diseases. Abstracts. New York: Cold Spring Harbor Laboratory Press, 1996; 12.
22. Patton DL, Sweeney YT, Kuo CC. Demonstration of delayed hypersensitivity in Chlamydia trachomatis salpingitis in monkeys: a pathogenic mechanism of tubal damage. J. Infect. Dis. 1994; 169: 680-3.
23. Makrides SC. Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol. Rev. 1996; 60: 512-38.
24. Hultgren SJ, Abraham S, Caparon M. Falk P, St Geme JW III, Normark S. Pilus and nonpilus bacterial adhesins: assembly and function in cell recognition. Cell 1993; 73: 887-901.